Mice lacking Mat1a (Mat1a-KO) exhibit chronically reduced hepatic SAMe levels, are more susceptible to steatosis and liver injury, and spontaneously develop steatohepatitis and HCC [85,86]. This evidence concerns the gene MAT1A and hepatocellular carcinoma.